Clinical Trials Browser

High-Energy Shock Waves × Other hematologic neoplasm × 30 days × Clear all

NCT01841723 2026-05-13

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Hairy Cell